Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
K PapavasileiouS Chatzipanagiotou

Abstract

In the present study, 194 Salmonella enterica strains, isolated from infected children and belonging to various serotypes, were investigated for their ability to form biofilms and the biofilm forms of the isolated strains were compared to their corresponding planktonic forms with respect to the antimicrobial susceptibility. For the biofilm-forming strains, the minimum inhibitory concentration for bacterial regrowth (MICBR) from the biofilm of nine clinically applicable antimicrobial agents was determined, and the results were compared to the respective MIC values of the planktonic forms. One hundred and nine S. enterica strains out of 194 (56%) belonging to 13 serotypes were biofilm-forming. The biofilm forms showed increased antimicrobial resistance compared to the planktonic bacteria. The highest resistance rates of the biofilm bacteria were observed with respect to gentamicin (89.9%) and ampicillin (84.4%), and the lowest rates with respect to ciprofloxacin and moxifloxacin (2.8% for both). A remarkable shift of the MICBR(50) and MICBR(90) toward resistance was observed in the biofilm forms as compared to the respective planktonic forms. The development of new consensus methods for the determination of the antimicrobial susc...Continue Reading

References

Dec 1, 1992·The Journal of Antimicrobial Chemotherapy·I G DuguidP Gilbert
Dec 1, 1988·The Journal of Antimicrobial Chemotherapy·M R BrownP Gilbert
Nov 1, 1987·Biomaterials·A G GristinaQ N Myrvik
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·B L ProsserR Cleeland
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
Mar 1, 1994·The Journal of Antimicrobial Chemotherapy·M J AshbyI A Critchley
Jan 1, 1995·Annual Review of Microbiology·J W CostertonH M Lappin-Scott
Apr 1, 1997·Advances in Dental Research·P GilbertI Foley
May 21, 1999·Science·J W CostertonE P Greenberg
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Apr 16, 2002·Infection and Immunity·A M ProutyJ S Gunn

❮ Previous
Next ❯

Citations

Aug 21, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Amruta NairT Balasaravanan
Aug 6, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abida RazaAbdul Haque
Jul 18, 2014·World Journal of Clinical Cases·Kimberly Tv JeroenseRachid Saouti
Dec 6, 2018·Frontiers in Microbiology·Jasmine MoshiriJohn S Gunn
Jan 1, 2014·Emerging Microbes & Infections·Zhen LiuRui Huang
Jan 21, 2020·Food Research International·Christina SakarikouEfstathios Giaouris
Dec 31, 2020·Microorganisms·Agata BiałuchaKrzysztof Skowron
Jul 22, 2021·Foodborne Pathogens and Disease·Dongyu ZhengXiang Huo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S MarakiY Tselentis
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Emmanouil GalanakisYiannis Tselentis
© 2021 Meta ULC. All rights reserved